Targeting nicotinic receptor antagonists as novel pharmacotherapies for tobacco dependence and relapse

Neuropsychopharmacology. 2009 Jan;34(1):244-6. doi: 10.1038/npp.2008.157.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Animals
  • Dopamine / metabolism
  • Drug Delivery Systems
  • Humans
  • Mice
  • Nicotinic Antagonists / therapeutic use*
  • Picolines / pharmacology
  • Rats
  • Recurrence
  • Tobacco Use Disorder / drug therapy*

Substances

  • N,N'-dodecane-1,12-diyl-bis-3-picolinium dibromide
  • Nicotinic Antagonists
  • Picolines
  • Dopamine